• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

Medtronic Has a Higher Target but the Near-Term Needs More Consolidation

I would look for some sideways to lower price action in the weeks ahead.
By BRUCE KAMICH
Oct 15, 2020 | 08:24 AM EDT
Stocks quotes in this article: MDT

In his first "Executive Decision" segment of Wednesday's Mad Money program, Jim Cramer spoke with Geoff Martha, CEO of Medtronic plc (MDT) , the medical device maker that just wrapped up its annual analyst day.

Martha explained that Medtronic has its best pipeline ever and his company has a great mission. He said the culture at Medtronic is about being bold, thinking big and making big bets on what's possible in the future.

Martha was bullish on his company's deep brain stimulation technology, which is able to sense brain signals and aid in therapies for Parkinson's disease, among other neurological conditions.

Medtronic is also disrupting the back and spine surgeries using robotics, Martha said. Currently, spine surgery is an art form that relies on the skills of your surgeon. But soon, he said, it will become a science that robots will be able to perform even better.

Let's check out the skills of the chart readers.

In this daily bar chart of MDT, below, we can see that prices have been climbing again since late June but our indicators are mixed. MDT is above the rising 50-day moving average line and above the bottoming 200-day moving average line. The 50-day line crossed above the 200-day line late last month for a bullish golden cross but the stock price has not done all that much since the buy signal.

Trading volume has been declining since March and the On-Balance-Volume (OBV) line made a low in March and another low in June. The rise since late June has not been smooth and the line has retreated in September and so far in October.

The trend-following Moving Average Convergence Divergence (MACD) oscillator has been trading around the zero line since May and that tells us there is not much "trend strength".  

In this weekly bar chart of MDT, below, we see a mixed picture. Prices are in an uptrend from the March low and they are above the 40-week moving average line but the line still has a negative slope which means the rally has not been strong enough to turn the trend positive.

The weekly OBV line shows weakness since the middle of August and that tells us that sellers of MDT have been more aggressive than buyers in this time frame.

The weekly MACD oscillator turned bullish in September as it crossed above the zero line but we can see that some momentum has been lost as the two moving averages have begun to narrow.

In this daily Point and Figure chart of MDT, below, we can see a recent upside breakout and a potential price target in the $129 area.  


Bottom line strategy: When we looked at MDT back on May 18, we wrote "MDT is in "no man's land" -- too far above where I would risk (below $90) and too far below a breakout point to give me confidence." Prices weakened into late June. Today I see prices are higher than back in May but the indicators are just not "in gear" with a bullish recommendation. I would look for some sideways to lower price action in the weeks ahead.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Life Sciences | Science | Mad Money | Executive Interview

More from Investing

We're in the Jaws of a Bear Market, Whether You Want to Admit It or Not

James "Rev Shark" DePorre
Sep 26, 2023 4:24 PM EDT

Not even big caps like Microsoft or Apple could save the indexes -- but here's why some bad news could help shake out remaining false hopes.

Why Would You Want to Own an Apple That's Going Bad?

Bruce Kamich
Sep 26, 2023 2:45 PM EDT

Here's why I wouldn't follow the advice of hold-but-don't trade AAPL.

Williams-Sonoma Stock Jumps After Private Equity Investment

Bruce Kamich
Sep 26, 2023 1:34 PM EDT

Let's see what the charts are telling us now.

Kohl's May Look Like a Bargain, but Buyer Beware

Bruce Kamich
Sep 26, 2023 11:33 AM EDT

Here's my take on the retailer's potential for a short-term bounce, based on the charts.

An Update on My Top Small-Cap Pick and What It Means for the Overall Market

James "Rev Shark" DePorre
Sep 26, 2023 11:30 AM EDT

The good news is that the corrective action is advancing and opportunities are developing.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:20 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Trading in Multiple Time Frames
  • 10:24 AM EDT BRUCE KAMICH

    This Could Get Messy

    A number of key stocks are getting close to import...
  • 01:41 PM EDT CHRIS VERSACE

    Latest AAP Podcast With Helene Meisler!

    Listen in as the Action Alerts PLUS podcast talks ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login